The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.

Lignende værker

• Chemotherapy of Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide (DTIC) and Nitrosourea Derivatives (BCNU, CCNU)
  af: Hill, George J., et al.
  Udgivet: (1974)
• Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
  af: Yang, Xi, et al.
  Udgivet: (2010)
• Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
  af: Lunn, J. M., et al.
  Udgivet: (1988)
• N,N-Dimethyl-3-phenyl­isoxazole-5-carbox­amide
  af: Wang, Li, et al.
  Udgivet: (2013)
• 1-(3,5-Dimethyl­phen­yl)-4,5-dimethyl-2-phenyl-1H-imidazole hemihydrate
  af: Gayathri, P., et al.
  Udgivet: (2010)